Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
CSPC PHARMA Tumbles 6% w/ Rating Downgraded to Sell by Daiwa; Finished Drug Sales Expected to Slow
Recommend 11 Positive 7 Negative 7 |
||||
|
||||
|
Facing heavier selling pressure after midday, CSPC PHARMA (01093.HK) once sank by 7.2% to an intraday low of HKD8.28. It last traded at HKD8.32, down 6.7%, with a turnover of HKD1.602 billion, the biggest decliner among blue chips. Daiwa has downgraded CSPC PHARMA's rating from Hold to Sell, as the stock price has already reflected business development. Estimating finished drug sales will slow down, it has also reduced its 2025-27 revenue forecasts. CSPC PHARMA's target price has been raised from HKD5 to HKD7.3 based on discounted cash flow valuation. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
